GPC3 CAR-T cell composition, and method for preparing and using the same.

JP7875600B2Active Publication Date: 2026-06-18EUTILEX CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
EUTILEX CO LTD
Filing Date
2021-03-18
Publication Date
2026-06-18

Smart Images

  • Figure 0007875600000008
    Figure 0007875600000008
  • Figure 0007875600000009
    Figure 0007875600000009
  • Figure 0007875600000010
    Figure 0007875600000010
Patent Text Reader

Abstract

Provided herein are CAR-T compositions directed against GPC3, including chimeric receptors, and engineered immune cells against GPC3. The present disclosure also provides vectors, compositions, and therapeutic methods using GPC3 antigen-binding molecules and engineered immune cells. The GPC3 CAR compositions provided herein can be used to treat certain cancers.
Need to check novelty before this filing date? Find Prior Art